搜索结果
ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
---|
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN036847 | hyperforin | (1R,5R,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione; C07608; Hyperforin; PDSP2_001346; 11079-53-1; (1R,5R,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-1-(2-methyl-1-oxopropyl)-8-(4-methylpent-3-enyl)bicyclo[3.3.1]non-3-ene-2,9-dione; Spectrum5_002025; NCGC00163120-01; hyperforin ; (1R,5R,7S,8R)-4-hydroxy-1-isobutyryl-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)bicyclo[3.3.1]non-3-ene-2,9-quinone | C36H54O4 | 551 | C1(O[H])=C(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C(=O)[C@@]([C@@](C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(C([H])([H])\C([H])=C(/C([H]) ([H])[H])\C([H])([H])[H])C([H])([H])C2([H])[H])(C(=O)C([H])(C([H])([H])[H])C([H])([H])[H])C(=O)[C@@]12C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H] |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE001098 | NFKBIA | EDAID2; IKBA; MAD-3; NFKBI | NFKB inhibitor alpha |
TCMBANKGE001180 | SMAD3 | HSPC193; HsT17436; JV15-2; LDS1C; LDS3; MADH3 | SMAD family member 3 |
TCMBANKGE000173 | BRAF | B-RAF1; B-raf; BRAF1; NS7; RAFB1 | B-Raf proto-oncogene, serine/threonine kinase |
TCMBANKGE010273 | REST | DFNA27; GINGF5; HGF5; NRSF; WT6; XBR | RE1 silencing transcription factor |
TCMBANKGE000071 | BTG2 | APRO1; PC3; TIS21 | BTG anti-proliferation factor 2 |
TCMBANKGE000909 | GLI1 | GLI; PAPA8; PPD1 | GLI family zinc finger 1 |
TCMBANKGE013791 | DHDDS | CIT; CPT; DEDSM; DS; HDS; RP59; hCIT | dehydrodolichyl diphosphate synthase subunit |
TCMBANKGE005002 | MYCN | MODED; N-myc; NMYC; ODED; bHLHe37 | MYCN proto-oncogene, bHLH transcription factor |
TCMBANKGE002654 | MXD3 | BHLHC13; MAD3; MYX | MAX dimerization protein 3 |